Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) Institutional Ownership

13F Institutional Holders and Ownership History from Q4 2024 to Q3 2025

Type / Class
Equity / Common stock, par value $0.001 per share
Symbol
APVO on Nasdaq
Shares outstanding
3,581,500
Price per share
$0.30
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
0
Total reported value
$0
Share change
-10,000
Value change
-$30,500
Number of holders
0
Price from insider filings
$0.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Ayrton Capital LLC 10% $107,445 358,150 Ayrton Capital LLC 30 Jun 2025
CVI Investments, Inc. 6.2% $138,000 200,000 CVI Investments, Inc. 03 Apr 2025
Hudson Bay Capital Management LP 5% 0% $52,853 76,598 0% Hudson Bay Capital Management LP 31 Dec 2024

As of 30 Sep 2025, 0 institutional investors reported holding 0 shares of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO). This represents 0% of the company’s total 3,581,500 outstanding shares.

Institutional Holders of Aptevo Therapeutics Inc. - Common stock, par value $0.001 per share (APVO) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q3 0 $0 -$30,500 $0.30 0
2025 Q2 10,000 $30,500 +$7,731 $3.05 1
2025 Q1 19,629 $22,769 -$168,977 $1.16 8
2024 Q4 48,491 $208,667 +$190,646 $4.31 12